{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210322",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "66833",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214231s000lbl.pdf",
              "date": "20210322",
              "type": "Label"
            },
            {
              "id": "66840",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/214231Orig1s000ltr.pdf",
              "date": "20210323",
              "type": "Letter"
            },
            {
              "id": "67117",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/214231Orig1s000TOC.html",
              "date": "20210419",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20260618",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "86333",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/214231Orig1s004ltr.pdf",
              "date": "20260623",
              "type": "Letter"
            },
            {
              "id": "86338",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/214231s004lbl.pdf",
              "date": "20260623",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA214231",
      "sponsor_name": "ZEALAND PHARMA",
      "openfda": {
        "application_number": [
          "NDA214231"
        ],
        "brand_name": [
          "ZEGALOGUE"
        ],
        "generic_name": [
          "DASIGLUCAGON"
        ],
        "manufacturer_name": [
          "Novo Nordisk"
        ],
        "product_ndc": [
          "0169-1912",
          "0169-1913"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "DASIGLUCAGON"
        ],
        "rxcui": [
          "2535238",
          "2535243",
          "2535247",
          "2535249"
        ],
        "spl_id": [
          "df9fed8a-f13a-4ef4-90cc-8ba51909d30c"
        ],
        "spl_set_id": [
          "14704879-872c-4967-8779-04a3bbdfb4e6"
        ],
        "package_ndc": [
          "0169-1913-01",
          "0169-1913-12",
          "0169-1913-02",
          "0169-1912-01",
          "0169-1912-12",
          "0169-1912-02"
        ],
        "nui": [
          "N0000190852",
          "N0000193923",
          "N0000009345"
        ],
        "pharm_class_epc": [
          "Antihypoglycemic Agent [EPC]"
        ],
        "pharm_class_moa": [
          "Glucagon Receptor Agonists [MoA]"
        ],
        "pharm_class_pe": [
          "Increased Glycogenolysis [PE]"
        ],
        "unii": [
          "AD4J2O47FQ"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "ZEGALOGUE",
          "active_ingredients": [
            {
              "name": "DASIGLUCAGON HYDROCHLORIDE",
              "strength": "EQ 0.6MG BASE/0.6ML (EQ 0.6MG BASE/0.6ML)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SOLUTION",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Discontinued"
        },
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "ZEGALOGUE (AUTOINJECTOR)",
          "active_ingredients": [
            {
              "name": "DASIGLUCAGON HYDROCHLORIDE",
              "strength": "EQ 0.6MG BASE/0.6ML (EQ 0.6MG BASE/0.6ML)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SOLUTION",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Discontinued"
        }
      ]
    }
  ]
}